Financhill
Back

Jasper Therapeutics Quote, Financials, Valuation and Earnings

Jasper Therapeutics Price Quote

$20.68
+0.21 (+1.03%)
(Updated: December 13, 2024 at 5:50 PM ET)

Jasper Therapeutics Key Stats

Sell
33
Jasper Therapeutics (JSPR) is a Sell

Day range:
$20.21 - $22.54
52-week range:
$4.24 - $31.01
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.67%

Volume:
155.9K
Avg. volume:
206.3K
1-year change:
355.7%
Market cap:
$307.1M
Revenue:
$0
EPS:
$-4.74

How Much Does Jasper Therapeutics Make?

Data Unavailable

Is Jasper Therapeutics Growing As A Company?

Data Unavailable

Jasper Therapeutics Stock Price Performance

What Is Jasper Therapeutics 52-Week High & Low?

Jasper Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Jasper Therapeutics?

Is Jasper Therapeutics Cash Flow Positive?

  • What Is JSPR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$57.9M
  • What Is Jasper Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $47.3M
  • What Is Jasper Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$686K

Jasper Therapeutics Return On Invested Capital

Data Unavailable

Jasper Therapeutics Earnings Date & Stock Price

Jasper Therapeutics Competitors

Jasper Therapeutics Dividend Yield

Jasper Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -15.38%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 68.78
Upside from Last Price: 235.99%

Major Shareholders

  • How many JSPR shares are owned by institutional investors?
    17.5M JSPR shares are owned by institutional investors
  • How many JSPR shares are owned by insiders?
    1.8M JSPR shares are owned by insiders